Early Stage Partners

Early Stage Partners is a venture capital firm founded in 2001 with the belief that the Midwest could produce a significant number of attractive technology companies

Since then, this belief has been borne out The Midwest is experiencing a surge of entrepreneurial energy and, as a result, is generating high quality investment opportunities Early Stage Partners has been pleased to capitalize on this trend

ESP Fund I, launched in 2002, and ESP Fund II, launched in 2008, are both expected to achieve top quartile returns among funds of a similar size and vintage Early Stage Partners experienced a banner year in 2014, when portfolio companies TOA Technologies, Simbionix and Reverse Medical were sold to strategic investors for a combined value approaching $750 million TOA Technologies, sold to Oracle, remains the largest ever exit for an Ohio-based software company

Recent News & Events

ShiftKey Makes a Strategic Investment in Workforce Management Platform OnShift

Dallas – June 22, 2022, – ShiftKey, the largest platform for connecting independent [

]

HistoSonics Hits Pivotal Clinical Trial Milestone In #HOPE4LIVER Studies

MINNEAPOLIS, May 31, 2022 /PRNewswire/ — HistoSonics, (www histosonics com), the developer and manufacturer of a [

]

OnShift Announces Groundbreaking Initiative to Address Workforce Shortage in Senior Care

The company will connect AI-driven technology with caregiver marketplaces for fast, intelligent [

]

Histotripsy is one such therapy that has the promise of changing cancer care

See Article: https://evtoday com/articles/2021-oct/interventional-oncology-fast-forward-to-the-future?c4src=current:feed Histotripsy is one such therapy that has the promise [

]

1801 East Ninth Street